Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-07-09

Clinical Trial Update: Combination Chemotherapy in Treating Patients With Previously Untreated Stage III or Stage IV Ovarian or Primary Peritoneal Cancer [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating combination chemotherapy for newly diagnosed Stage III/IV ovarian cancer or primary peritoneal cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Gynecologic Oncology Group | Conditions: Ovarian Cancer, Primary Peritoneal Cavity Cancer | Phase 1 | Status: TERMINATED